INVO Fertility, Inc. (IVF): debt financing — INVO Bioscience raises $100k in demand promissory notes from CEO, CFO, and related party

INVO Fertility, Inc.

Received $25k from CEO Steven Shum, $25k from entity controlled by CFO Andrea Goren, and $50k from JAG Multi Investments LLC.
Interest-free until Jan 31, 2023; thereafter 10% annual interest from issuance date.
Notes payable at maturity with 10% financing fee plus accrued interest; callable with 10 days notice after 30 days.

item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INVO Fertility, Inc. incurred loan of $100,000 at 10% annual interest.

Instrument: loan
Principal: $100,000
Rate: 10% annual interest
Event: incurrence

Exact text from the filing

On December 13, 2022, INVO Bioscience, Inc. (the “Company”) received $100,000 through the issuance of demand promissory notes of which (1) $25,000 was received from our chief executive officer, Steven Shum, (2) $25,000 was received from an entity controlled by our chief financial officer, Andrea Goren, and (3) $50,000 was received from JAG Multi Investments LLC (“JAG”), a related party to Mr. Goren, who is a beneficiary of JAG but does not have any control over JAG’s investment decisions with respect to the Company.

View on SEC.gov

90 debt financings filed in the last 30 days. Browse all debt financings →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-035812

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.